Towards Healthcare

News

Your marketplace is evolving, your competitors are readjusting – but instead of reacting you can proact

FDA’s New Conditional Pathway for Ultra-Rare Diseases Sparks Mixed Reactions at Bio2025
25 June 2025

FDA’s New Conditional Pathway for Ultra-Rare Diseases Sparks Mixed Reactions at Bio2025

Questions on FDA Conditions Image Credits: Biospace New Regulatory Pathway At Bio2025, rare diseases leaders Yale, Ultragenyx, and Amylyx raised a few questions on the new regulatory pathways introduced by Marty Makary, an FDA commissioner. The leaders also acknowledged the efforts and addition...

GE Healthcare Unveils AI-Powered Theranostics Software to Boost Cancer Diagnosis and Treatment
24 June 2025

GE Healthcare Unveils AI-Powered Theranostics Software to Boost Cancer Diagnosis and Treatment

GE Healthcare’s Approach to the Latest Technological Advancement Image Credits: MedTech Spectrum Announcement This year, at the Society of Nuclear Medicine and Molecular Imaging annual meeting, GE Healthcare highlighted an innovative technological solution by presenting an advanced portfo...

CHMP Recommends Sarclisa Combo for Newly Diagnosed Multiple Myeloma Patients
24 June 2025

CHMP Recommends Sarclisa Combo for Newly Diagnosed Multiple Myeloma Patients

CHMP’s Opinion on Sarclisa Image Credits: Pharmaceutical Technology Announcement The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommendation for the approval of Sarclisa, combining dexamethasone, bortezomib, and lenalidomide for the induction...

Zivo Bioscience Partners to Boost Poultry Health with New Immune-Boosting Solution
24 June 2025

Zivo Bioscience Partners to Boost Poultry Health with New Immune-Boosting Solution

Zivo Bioscience Partnered with Animal Health Companies to Advance Poultry Image Credits: AInvest Announcement Zivo Bioscience, Inc., an agtech R&D and biotech company known for its nutritional products and development of therapeutic has partnered with a leading animal health company to inve...

Vertex and Ono Pharmaceutical Partner to Bring New Kidney Disease Treatment to Japan and South Korea
24 June 2025

Vertex and Ono Pharmaceutical Partner to Bring New Kidney Disease Treatment to Japan and South Korea

Vertex and Ono Pharmaceutical Entered into an Agreement Image Credits: Biospectrum Asia Announcement Vertex and Ono Pharmaceutical have signed a license agreement to develop and market Povetacicept in South Korea and Japan. Povetacicept is a therapeutic for various serious B-cell-mediated disea...

Medical Taiwan 2025 Highlights Smart Healthcare and AI Innovations for Ageing Population
23 June 2025

Medical Taiwan 2025 Highlights Smart Healthcare and AI Innovations for Ageing Population

Taiwan's Trade Show Introduced Smart Healthcare Image Credits: Techsauce Announcement The Taiwan External Trade Development Council held a medical trade show, Medical Taiwan 2025, which attracted 316 exhibitors from 14 countries. The show highlighted advanced technology products fueled by gover...

Superlab Suisse to Open New Life Sciences Lab at Geneva’s Campus Biotech by 2026
23 June 2025

Superlab Suisse to Open New Life Sciences Lab at Geneva’s Campus Biotech by 2026

Superlab Suisse in Geneva by 2026 Image Credits: Manufacturing Chemist Announcement Superlab Suisse has officially announced its fourth Swiss laboratory facility opening at Campus Biotech in Geneva. The new facility will be inaugurated by January 2026. The location will provide a vast space for...

FDA Approves Dupixent by Regeneron and Sanofi for Bullous Pemphigoid Treatment
23 June 2025

FDA Approves Dupixent by Regeneron and Sanofi for Bullous Pemphigoid Treatment

Regeneron and Sanofi Receive Approval for the Medication Image Credits: FirstWord Pharma Announcement Sanofi and Regeneron Pharmaceuticals, Inc. received approval for Dupixent (dupilumab), a medication for adults suffering from bullous pemphigoid (BP). The approval of this medication was based ...

MorningStar Expands SmartVascular Dx Heart Test Access to California Patients
23 June 2025

MorningStar Expands SmartVascular Dx Heart Test Access to California Patients

MorningStar’s Test Reached California Image Credits: AInvest Announcement MorningStar Laboratories, LLC (MSL), a global developer of precision diagnostic tests that analyze clinical needs, is proud to announce the availability of the Smartvascular Dx test (PULS Cardiac test) to patients i...

Brenus Pharma and InSphero Present Promising 3D Tumor Model Results for Colorectal Cancer Therapy
20 June 2025

Brenus Pharma and InSphero Present Promising 3D Tumor Model Results for Colorectal Cancer Therapy

Brenus Pharma and InSphero’s Presentation Presentation InSphero, a leader in 3D cell-based assay technologies, of Swiss and Brenus pharma, a French biotech known for its next-generation excellent immunotherapies, showcased data at the European Association for Cancer Research 2025 annual co...